Long-term Outcome of Chilblains Associated with SARS-CoV-2
Numerous cases of chilblains have been observed in the course if the COVID-19 pandemic. The aims of this study were to provide comprehensive follow-up data for patients reporting chilblains, and to determine the risk factors for incomplete recovery. Patients referred to 5 hospitals in France between...
Saved in:
Main Authors: | Florence Poizeau (Author), Sébastien Barbarot (Author), Yannick Le Corre (Author), Emilie Brenaut (Author), Mahtab Samimi (Author), Hélène Aubert (Author), Alexis Toubel (Author), Alain Dupuy (Author) |
---|---|
Format: | Book |
Published: |
Medical Journals Sweden,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Vaccination Safety in Patients who have had SARS-CoV-2-induced Chilblains
by: Florence Poizeau, et al.
Published: (2022) -
Immunologic skin signatures in SARS-CoV-2-negative patients with chilblain-like lesions
by: Maria Vastarella, MD, et al.
Published: (2021) -
SARS-CoV-2 Vaccination and Chilblain-like Lesions: What Do We Know So Far?
by: Taha Gul Shaikh, et al.
Published: (2022) -
Type I Interferon Signature in Chilblains Following SARS-CoV-2 mRNA Vaccine: A Case Report
by: Karim Souaid, et al.
Published: (2021) -
Update on Functional Inhibitors of Acid Sphingomyelinase (FIASMAs) in SARS-CoV-2 Infection
by: Gwenolé Loas, et al.
Published: (2021)